.png){kind=icon}
P
Palle Bekker Jeppesen
H-index:52
Citation Count:1.1万
Views:0
Biography
No content for now.
Education
No content for now.
Work Experience
No content for now.
Honors & Awards
No content for now.
Investigation of the stool microbiome of Short Bowel Syndrome patients before and after a 24-week treatment with the Glucagon-like Peptide 2 analog glepaglutide
短肠综合征患者在接受24周胰高血糖素样肽2类似物glepaglutide治疗前后粪便微生物组的调查
GLP-2 Analogues in Short Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
GLP-2类似物在短肠综合征中的应用：一项随机对照试验的系统评价和Meta分析
Assessment of liver stiffness and steatosis in patients with intestinal failure: a cross-sectional study
评估肠衰竭患者肝脏刚度和脂肪变性的研究：一项横断面研究
Increased BMI favors weaning in patients with chronic intestinal failure due to short bowel syndrome: a retrospective cohort study in Italy
体重指数升高有利于短肠综合征导致的慢性肠功能衰竭患者的断管喂养：一项意大利回顾性队列研究
Outcomes of Glepaglutide on Intestinal Absorption and Parenteral Support in Patients with Short Bowel Syndrome
Glepaglutide对短肠综合征患者肠道吸收和肠外支持的影响
clinical nutrition
IF2.6
Long-term antithrombotic therapy practices in adult patients with short bowel syndrome following acute mesenteric ischemia: An international case-based survey
成人短肠综合征患者在急性肠系膜缺血后长期抗血栓治疗实践：一项基于病例的国际调查
clinical nutrition
IF2.6
Patient and clinician satisfaction with intestinal failure telemedicine consultations
患者和临床医生对肠衰竭远程医疗会诊的满意度
clinical nutrition
IF2.6
Glepaglutide, a Long-Acting Glucagon-like Peptide-2 Analogue, Reduces Parenteral Support in Patients With Short Bowel Syndrome: A Phase 3 Randomized Controlled Trial
Glepaglutide，一种长效胰高血糖素样肽-2类似物，可减少短肠综合征患者的肠外营养支持：一项III期随机对照试验
GASTROENTEROLOGY
IF25.1
RETRACTED: Avoiding the use of long-term parenteral support in patients without intestinal failure: A position paper from the European Society of Clinical Nutrition & Metabolism, the European Society of Neurogastroenterology and Motility and the Rome Foundation for Disorders of Gut-Brain Interaction
CLINICAL NUTRITION
IF7.4
